Nuclear Medicine
131I MIBG BACON (R&D)
Name:
131I MIBG Bacon (R&D)
Active Principle:
131I- Meta Iodo Benzylguanidine or 131I- Iobenguane
Therapeutic Action:
It is indicated for the diagnosis and location of neuroendocrine tumors, pheochromocytoma, medullary thyroid cancer, primary neuroblastomas and their metastases, paragangliomas and thymomas, among other pathologies.
Nuclear Medicine
131I MIBG BACON (R&D)
Name:
131I MIBG Bacon (R&D)
Active Principle:
131I- Meta Iodo Benzylguanidine or 131I- Iobenguane
Therapeutic Action:
It is indicated for the diagnosis and location of neuroendocrine tumors, pheochromocytoma, medullary thyroid cancer, primary neuroblastomas and their metastases, paragangliomas and thymomas, among other pathologies.
RELATED PRODUCTS
-
FLPET (R+D)
FLPET (R+D)It is indicated for the detection and evaluation of cell proliferation in lung, breast, colorectal, melanoma, soft tissue sarcoma and primary or metastatic brain tumors. It allows to predict the aggressiveness... -
177Lu DOTATATE (I+D)
177Lu DOTATATE (I+D)It is a radiolabeled somatostatin analog indicated for: - The treatment of gastroenteropancreatic tumors positive for the somatostatin receptor. Neuroendocrine tumors (GEP-NETs), including the foregut... -
PSMA (R+D)
PSMA (R+D)It is indicated for the detection and evaluation of prostate cancer from the initial diagnosis to the monitoring of castration-resistant metastases.

